Clinical Trial Update: Post Authorization Safety Study of the Pandemic A/H1N1 Influenza Vaccines in Children and Adults

View source ↗

Summary

This clinical trial update reports completion of a post-authorization safety study evaluating pandemic A/H1N1 influenza vaccines in children and adults.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Swine Influenza

Drugs mentioned

• Panenza (Influenza vaccine, swine-origin A/H1N1)

Snippet

Sponsor: Sanofi Pasteur, a Sanofi Company | Conditions: Influenza, Swine-Origin A/H1N1 Influenza Virus | Status: COMPLETED